How effective is Johnson & Johnson's ICOTYDE treatment?
Johnson & Johnson releases positive two-year results for ICOTYDE treatment
What the source reports (AI summary)
Johnson & Johnson presented data from a Phase 3 study on the efficacy of its ICOTYDE treatment for plaque psoriasis, showing sustained results over two years.
AI interpretation: Impact analysis
The news is scientific and pharmaceutical regarding the progress of a private medical treatment.
Read the full story on prnewswire.com
Headline, summary and analysis generated by AI without human review on 2026-10-02 11:40 UTC. They may contain errors: check the source. Report an error
More news from Japan
- Taiwan conducts maritime emergency drill with international cooperation
- Japan imposes sanctions on Russian firms and entities in other countries
- Gwangju Biennale explores the historical archive of political apologies
- US dollar rises as fiscal instability increases in France
- Japan reports rise in manufacturing confidence alongside higher residency fees
- Japanese yen exchange rate remains stable against the Egyptian pound